XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the three and nine months ended September 30, 2024 and 2023 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:

Increase/(Decrease) for theIncrease/(Decrease) for the
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Cost of sales$441 $477 $1,266 $1,436 
Operating expenses3,710 3,272 11,521 10,831 
Net earnings(3,188)(2,884)(9,815)(9,447)
Schedule of Stock Option Activity
Option activity for the nine months ended September 30, 2024 and 2023 is summarized below:
For the Nine Months Ended September 30, 2024Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 20231,078 $104.38 $47,889 
Granted113 143.43 
Exercised(198)75.94 
Forfeited(2)137.06 
Canceled— — 
Outstanding as of September 30, 2024991 $114.49 $60,932 6.0
Exercisable as of September 30, 2024626 $99.39 $47,926 4.6
For the Nine Months Ended September 30, 2023Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 20221,045 $99.82 $27,221 
Granted109 138.09 
Exercised(47)82.70 
Forfeited(11)131.79 
Canceled(1)138.07 
Outstanding as of September 30, 20231,095 $104.00 $26,825 5.9
Exercisable as of September 30, 2023728 $88.01 $26,512 4.6
Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the three and nine months ended September 30, 2024 and 2023 is as follows:

 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Weighted-average fair value of options granted$— $— $44.52 $40.91 
Total intrinsic value of stock options exercised ($000s)$5,372 $100 $16,693 $2,280 
Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the nine months ended September 30, 2024 and 2023 is summarized below:
Nine Months Ended September 30,
20242023
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31116 $133.06 122 $124.42 
Granted50 147.49 39 137.48 
Vested(34)120.01 (34)111.48 
Forfeited(3)141.23 (4)128.06 
Non-vested balance as of September 30129 $141.94 123 $132.01 
Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the nine months ended September 30, 2024 and 2023 is summarized below:

Nine Months Ended September 30,
20242023
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 3176 $135.25 70 $127.69 
Granted47 152.28 42 139.66
Vested(44)106.57 (36)98.84
Forfeited— — — —
Non-vested balance as of September 3079 $150.73 76 $135.25